Drug Policy Reform
The evidence moved.
Public opinion is still catching up.
Therapeutic research has raced ahead of public perception. We measure the gap between what the science shows and what people believe — and test the communication strategies that close it.
We're building an open resource for the psychedelics movement
The Social Insights Hub will give advocates in all 50 states free access to polling, audience research, and strategy playbooks. The first tools are already live — and we're fundraising with MAPS to build the rest.
Executive Summary
The essential data and strategy from across our studies, all on one page. Read it in five minutes & download the PDF.
Latest data & strategy
The Psychedelic Five: how to talk to each of the five distinct audiences
Americans' views on psychedelics cluster into five distinct personas. A segmentation report showing who they are, what they believe, and how to communicate effectively with each.
Numbers don't have faces: the paradoxical power of anecdotes
The evidence that convinces a scientist rarely moves an audience. A rule of thumb for when to speak from the data and when to tell a story.
Full report: Americans' opinions of psychedelics and support for policy reform
2025 national findings, plus a policy experiment showing how policy design shapes support and opposition.
What people think of when they hear the term "psychedelics"
Open-ended responses reveal which helpful and harmful mental models are most common.
Reflecting on Question 4: a post-election analysis of the results in Massachusetts
Why the measure fell 43–57: legalization framing, unfamiliar substances, and undecideds defaulting to "no."
How likely is Massachusetts to pass its psychedelics ballot measure?
Our pre-election analysis of the polls, past ballot measures, and prediction markets on Question 4.
Full report: How Americans think about psychedelics
Our first national deep-dive, with an executive summary and key strategy takeaways.
How can 1,000 people tell us what the whole nation thinks?
Why a well-conducted survey of 1,000 people reliably captures the opinions of an entire country.
Most Americans overestimate the harms of psychedelics
Perceived harm of specific substances, benchmarked against tobacco and alcohol.
How to communicate uncertainties without losing credibility
When acknowledging uncertainty helps your message — and the situations where it backfires.
Support for MDMA treatment of PTSD far outnumbers opposition
Where the public stands on one of mental health's most promising recent advances.
Who is trusted (and who is not) for information about psychedelics?
The messengers who move undecided audiences — and the ones who backfire.